Damian Green Shares His Experience as Chief of the Division of Transplantation and Cellular Therapy at Sylvester Cancer Center
Sylvester Comprehensive Cancer Center shared a post on LinkedIn:
“Chief of the Division of Transplantation and Cellular Therapy, Dr. Damian Green, isn’t wasting any time building out Sylvester’s cellular therapy program. As the Ron and Nedra Kalish Family Endowed Chair in Stem Cell Transplantation and Assistant Director of Translational Research Dr. Green is leading efforts to expand and accelerate access to next-generation cell therapies for blood and solid cancers. He’s focused on scaling the division and laying the groundwork to bring more life-saving therapies to patients.
How does cellular therapy work?
Modern cell therapy harnesses the power of the immune system. This system has been refined in living organisms over hundreds of millions of years. It is remarkably sophisticated.
With CAR-T cells, we first find markers, which are ideally unique to the tumor cell, since we don’t want our therapy to attack normal cells. Then, we take a patient’s own T cells and modify them to see those markers as the enemy. When we infuse them, they expand in the patient’s body and target the tumor cells for destruction. There are other types of cellular therapy and we are actively exploring many avenues.
Read our Q and A to learn more about Dr. Green’s work and goals at Sylvester.”
More posts featuring Sylvester Comprehensive Cancer Center.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023